The global Measles, Mumps and Rubella (MMR) Vaccines market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Measles can lead to otitis media, tracheitis, encephalitis and other complications.Mumps can cause hearing loss and inflammation of the ovaries or testes.German measles can lead to arthritis, encephalitis, conjunctivitis, miscarriage or birth defects.
This report aims to provide a comprehensive presentation of the global market for Measles, Mumps and Rubella (MMR) Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Measles, Mumps and Rubella (MMR) Vaccines. This report contains market size and forecasts of Measles, Mumps and Rubella (MMR) Vaccines in global, including the following market information:
- Global Measles, Mumps and Rubella (MMR) Vaccines Market Revenue, 2018-2023, 2024-2032, ($ millions)
- Global Measles, Mumps and Rubella (MMR) Vaccines Market Sales, 2018-2023, 2024-2032, (K Doses)
- Global top five Measles, Mumps and Rubella (MMR) Vaccines companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Monovalent Vaccine Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Measles, Mumps and Rubella (MMR) Vaccines include Medlmmune, Johnson & Johnson, Merck, Sanofi, Serum, Bavarian Nordic, Astellas Pharma, Emergent BioSolutions and GlaxoSmithKline, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Measles, Mumps and Rubella (MMR) Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Measles, Mumps and Rubella (MMR) Vaccines Market, by Type, 2018-2023, 2024-2032 ($ Millions) & (K Doses)
Global Measles, Mumps and Rubella (MMR) Vaccines Market Segment Percentages, by Type, 2022 (%)
- Monovalent Vaccine
- Polyvalent Vaccine
Global Measles, Mumps and Rubella (MMR) Vaccines Market, by Application, 2018-2023, 2024-2032 ($ Millions) & (K Doses)
Global Measles, Mumps and Rubella (MMR) Vaccines Market Segment Percentages, by Application, 2022 (%)
- Immune Center
- Vaccine Development Agencies and Organizations
- Hospital
- Laboratory
- Biotechnology and Biopharmaceutical Companies
Global Measles, Mumps and Rubella (MMR) Vaccines Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions) & (K Doses)
Global Measles, Mumps and Rubella (MMR) Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Measles, Mumps and Rubella (MMR) Vaccines revenues in global market, 2018-2023 (Estimated), ($ millions)
- Key companies Measles, Mumps and Rubella (MMR) Vaccines revenues share in global market, 2022 (%)
- Key companies Measles, Mumps and Rubella (MMR) Vaccines sales in global market, 2018-2023 (Estimated), (K Doses)
- Key companies Measles, Mumps and Rubella (MMR) Vaccines sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Medlmmune
- Johnson & Johnson
- Merck
- Sanofi
- Serum
- Bavarian Nordic
- Astellas Pharma
- Emergent BioSolutions
- GlaxoSmithKline
- Pfizer
- CSL
Outline of Major Chapters:
Chapter 1: Introduces the definition of Measles, Mumps and Rubella (MMR) Vaccines, market overview.
Chapter 2: Global Measles, Mumps and Rubella (MMR) Vaccines market size in revenue and volume.
Chapter 3: Detailed analysis of Measles, Mumps and Rubella (MMR) Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments
by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments
by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Measles, Mumps and Rubella (MMR) Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Measles, Mumps and Rubella (MMR) Vaccines capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Measles, Mumps and Rubella (MMR) Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Measles, Mumps and Rubella (MMR) Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Measles, Mumps and Rubella (MMR) Vaccines Overall Market Size
2.1 Global Measles, Mumps and Rubella (MMR) Vaccines Market Size: 2022 VS 2032
2.2 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue, Prospects & Forecasts: 2018-2032
2.3 Global Measles, Mumps and Rubella (MMR) Vaccines Sales: 2018-2032
3 Company Landscape
3.1 Top Measles, Mumps and Rubella (MMR) Vaccines Players in Global Market
3.2 Top Global Measles, Mumps and Rubella (MMR) Vaccines Companies Ranked by Revenue
3.3 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue by Companies
3.4 Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Companies
3.5 Global Measles, Mumps and Rubella (MMR) Vaccines Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Measles, Mumps and Rubella (MMR) Vaccines Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Measles, Mumps and Rubella (MMR) Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Measles, Mumps and Rubella (MMR) Vaccines Players in Global Market
3.8.1 List of Global Tier 1 Measles, Mumps and Rubella (MMR) Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 Measles, Mumps and Rubella (MMR) Vaccines Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Measles, Mumps and Rubella (MMR) Vaccines Market Size Markets, 2022 & 2032
4.1.2 Monovalent Vaccine
4.1.3 Polyvalent Vaccine
4.2 By Type - Global Measles, Mumps and Rubella (MMR) Vaccines Revenue & Forecasts
4.2.1 By Type - Global Measles, Mumps and Rubella (MMR) Vaccines Revenue, 2018-2023
4.2.2 By Type - Global Measles, Mumps and Rubella (MMR) Vaccines Revenue, 2024-2032
4.2.3 By Type - Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share, 2018-2032
4.3 By Type - Global Measles, Mumps and Rubella (MMR) Vaccines Sales & Forecasts
4.3.1 By Type - Global Measles, Mumps and Rubella (MMR) Vaccines Sales, 2018-2023
4.3.2 By Type - Global Measles, Mumps and Rubella (MMR) Vaccines Sales, 2024-2032
4.3.3 By Type - Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share, 2018-2032
4.4 By Type - Global Measles, Mumps and Rubella (MMR) Vaccines Price (Manufacturers Selling Prices), 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2022 & 2032
5.1.2 Immune Center
5.1.3 Vaccine Development Agencies and Organizations
5.1.4 Hospital
5.1.5 Laboratory
5.1.6 Biotechnology and Biopharmaceutical Companies
5.2 By Application - Global Measles, Mumps and Rubella (MMR) Vaccines Revenue & Forecasts
5.2.1 By Application - Global Measles, Mumps and Rubella (MMR) Vaccines Revenue, 2018-2023
5.2.2 By Application - Global Measles, Mumps and Rubella (MMR) Vaccines Revenue, 2024-2032
5.2.3 By Application - Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share, 2018-2032
5.3 By Application - Global Measles, Mumps and Rubella (MMR) Vaccines Sales & Forecasts
5.3.1 By Application - Global Measles, Mumps and Rubella (MMR) Vaccines Sales, 2018-2023
5.3.2 By Application - Global Measles, Mumps and Rubella (MMR) Vaccines Sales, 2024-2032
5.3.3 By Application - Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share, 2018-2032
5.4 By Application - Global Measles, Mumps and Rubella (MMR) Vaccines Price (Manufacturers Selling Prices), 2018-2032
6 Sights by Region
6.1 By Region - Global Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2022 & 2032
6.2 By Region - Global Measles, Mumps and Rubella (MMR) Vaccines Revenue & Forecasts
6.2.1 By Region - Global Measles, Mumps and Rubella (MMR) Vaccines Revenue, 2018-2023
6.2.2 By Region - Global Measles, Mumps and Rubella (MMR) Vaccines Revenue, 2024-2032
6.2.3 By Region - Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share, 2018-2032
6.3 By Region - Global Measles, Mumps and Rubella (MMR) Vaccines Sales & Forecasts
6.3.1 By Region - Global Measles, Mumps and Rubella (MMR) Vaccines Sales, 2018-2023
6.3.2 By Region - Global Measles, Mumps and Rubella (MMR) Vaccines Sales, 2024-2032
6.3.3 By Region - Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share, 2018-2032
6.4 North America
6.4.1 By Country - North America Measles, Mumps and Rubella (MMR) Vaccines Revenue, 2018-2032
6.4.2 By Country - North America Measles, Mumps and Rubella (MMR) Vaccines Sales, 2018-2032
6.4.3 US Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2018-2032
6.4.4 Canada Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2018-2032
6.4.5 Mexico Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2018-2032
6.5 Europe
6.5.1 By Country - Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue, 2018-2032
6.5.2 By Country - Europe Measles, Mumps and Rubella (MMR) Vaccines Sales, 2018-2032
6.5.3 Germany Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2018-2032
6.5.4 France Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2018-2032
6.5.5 U.K. Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2018-2032
6.5.6 Italy Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2018-2032
6.5.7 Russia Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2018-2032
6.5.8 Nordic Countries Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2018-2032
6.5.9 Benelux Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2018-2032
6.6 Asia
6.6.1 By Region - Asia Measles, Mumps and Rubella (MMR) Vaccines Revenue, 2018-2032
6.6.2 By Region - Asia Measles, Mumps and Rubella (MMR) Vaccines Sales, 2018-2032
6.6.3 China Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2018-2032
6.6.4 Japan Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2018-2032
6.6.5 South Korea Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2018-2032
6.6.6 Southeast Asia Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2018-2032
6.6.7 India Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2018-2032
6.7 South America
6.7.1 By Country - South America Measles, Mumps and Rubella (MMR) Vaccines Revenue, 2018-2032
6.7.2 By Country - South America Measles, Mumps and Rubella (MMR) Vaccines Sales, 2018-2032
6.7.3 Brazil Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2018-2032
6.7.4 Argentina Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2018-2032
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Measles, Mumps and Rubella (MMR) Vaccines Revenue, 2018-2032
6.8.2 By Country - Middle East & Africa Measles, Mumps and Rubella (MMR) Vaccines Sales, 2018-2032
6.8.3 Turkey Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2018-2032
6.8.4 Israel Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2018-2032
6.8.5 Saudi Arabia Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2018-2032
6.8.6 UAE Measles, Mumps and Rubella (MMR) Vaccines Market Size, 2018-2032
7 Manufacturers & Brands Profiles
7.1 Medlmmune
7.1.1 Medlmmune Company Summary
7.1.2 Medlmmune Business Overview
7.1.3 Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Major Product Offerings
7.1.4 Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Sales and Revenue in Global (2018-2023)
7.1.5 Medlmmune Key News & Latest Developments
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Company Summary
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson Measles, Mumps and Rubella (MMR) Vaccines Major Product Offerings
7.2.4 Johnson & Johnson Measles, Mumps and Rubella (MMR) Vaccines Sales and Revenue in Global (2018-2023)
7.2.5 Johnson & Johnson Key News & Latest Developments
7.3 Merck
7.3.1 Merck Company Summary
7.3.2 Merck Business Overview
7.3.3 Merck Measles, Mumps and Rubella (MMR) Vaccines Major Product Offerings
7.3.4 Merck Measles, Mumps and Rubella (MMR) Vaccines Sales and Revenue in Global (2018-2023)
7.3.5 Merck Key News & Latest Developments
7.4 Sanofi
7.4.1 Sanofi Company Summary
7.4.2 Sanofi Business Overview
7.4.3 Sanofi Measles, Mumps and Rubella (MMR) Vaccines Major Product Offerings
7.4.4 Sanofi Measles, Mumps and Rubella (MMR) Vaccines Sales and Revenue in Global (2018-2023)
7.4.5 Sanofi Key News & Latest Developments
7.5 Serum
7.5.1 Serum Company Summary
7.5.2 Serum Business Overview
7.5.3 Serum Measles, Mumps and Rubella (MMR) Vaccines Major Product Offerings
7.5.4 Serum Measles, Mumps and Rubella (MMR) Vaccines Sales and Revenue in Global (2018-2023)
7.5.5 Serum Key News & Latest Developments
7.6 Bavarian Nordic
7.6.1 Bavarian Nordic Company Summary
7.6.2 Bavarian Nordic Business Overview
7.6.3 Bavarian Nordic Measles, Mumps and Rubella (MMR) Vaccines Major Product Offerings
7.6.4 Bavarian Nordic Measles, Mumps and Rubella (MMR) Vaccines Sales and Revenue in Global (2018-2023)
7.6.5 Bavarian Nordic Key News & Latest Developments
7.7 Astellas Pharma
7.7.1 Astellas Pharma Company Summary
7.7.2 Astellas Pharma Business Overview
7.7.3 Astellas Pharma Measles, Mumps and Rubella (MMR) Vaccines Major Product Offerings
7.7.4 Astellas Pharma Measles, Mumps and Rubella (MMR) Vaccines Sales and Revenue in Global (2018-2023)
7.7.5 Astellas Pharma Key News & Latest Developments
7.8 Emergent BioSolutions
7.8.1 Emergent BioSolutions Company Summary
7.8.2 Emergent BioSolutions Business Overview
7.8.3 Emergent BioSolutions Measles, Mumps and Rubella (MMR) Vaccines Major Product Offerings
7.8.4 Emergent BioSolutions Measles, Mumps and Rubella (MMR) Vaccines Sales and Revenue in Global (2018-2023)
7.8.5 Emergent BioSolutions Key News & Latest Developments
7.9 GlaxoSmithKline
7.9.1 GlaxoSmithKline Company Summary
7.9.2 GlaxoSmithKline Business Overview
7.9.3 GlaxoSmithKline Measles, Mumps and Rubella (MMR) Vaccines Major Product Offerings
7.9.4 GlaxoSmithKline Measles, Mumps and Rubella (MMR) Vaccines Sales and Revenue in Global (2018-2023)
7.9.5 GlaxoSmithKline Key News & Latest Developments
7.10 Pfizer
7.10.1 Pfizer Company Summary
7.10.2 Pfizer Business Overview
7.10.3 Pfizer Measles, Mumps and Rubella (MMR) Vaccines Major Product Offerings
7.10.4 Pfizer Measles, Mumps and Rubella (MMR) Vaccines Sales and Revenue in Global (2018-2023)
7.10.5 Pfizer Key News & Latest Developments
7.11 CSL
7.11.1 CSL Company Summary
7.11.2 CSL Measles, Mumps and Rubella (MMR) Vaccines Business Overview
7.11.3 CSL Measles, Mumps and Rubella (MMR) Vaccines Major Product Offerings
7.11.4 CSL Measles, Mumps and Rubella (MMR) Vaccines Sales and Revenue in Global (2018-2023)
7.11.5 CSL Key News & Latest Developments
8 Global Measles, Mumps and Rubella (MMR) Vaccines Production Capacity, Analysis
8.1 Global Measles, Mumps and Rubella (MMR) Vaccines Production Capacity, 2018-2032
8.2 Measles, Mumps and Rubella (MMR) Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Measles, Mumps and Rubella (MMR) Vaccines Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Measles, Mumps and Rubella (MMR) Vaccines Supply Chain Analysis
10.1 Measles, Mumps and Rubella (MMR) Vaccines Industry Value Chain
10.2 Measles, Mumps and Rubella (MMR) Vaccines Upstream Market
10.3 Measles, Mumps and Rubella (MMR) Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Measles, Mumps and Rubella (MMR) Vaccines Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Measles, Mumps and Rubella (MMR) Vaccines in Global Market
Table 2. Top Measles, Mumps and Rubella (MMR) Vaccines Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Share by Companies, 2018-2023
Table 5. Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Companies, (K Doses), 2018-2023
Table 6. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Measles, Mumps and Rubella (MMR) Vaccines Price (2018-2023) & (USD/Dose)
Table 8. Global Manufacturers Measles, Mumps and Rubella (MMR) Vaccines Product Type
Table 9. List of Global Tier 1 Measles, Mumps and Rubella (MMR) Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Measles, Mumps and Rubella (MMR) Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Global Measles, Mumps and Rubella (MMR) Vaccines Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Measles, Mumps and Rubella (MMR) Vaccines Revenue (US$, Mn), 2024-2032
Table 14. By Type - Global Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), 2018-2023
Table 15. By Type - Global Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), 2024-2032
Table 16. By Application ? Global Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2022 & 2032
Table 17. By Application - Global Measles, Mumps and Rubella (MMR) Vaccines Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Measles, Mumps and Rubella (MMR) Vaccines Revenue (US$, Mn), 2024-2032
Table 19. By Application - Global Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), 2018-2023
Table 20. By Application - Global Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), 2024-2032
Table 21. By Region ? Global Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2022 VS 2032
Table 22. By Region - Global Measles, Mumps and Rubella (MMR) Vaccines Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Measles, Mumps and Rubella (MMR) Vaccines Revenue (US$, Mn), 2024-2032
Table 24. By Region - Global Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), 2018-2023
Table 25. By Region - Global Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), 2024-2032
Table 26. By Country - North America Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2024-2032
Table 28. By Country - North America Measles, Mumps and Rubella (MMR) Vaccines Sales, (K Doses), 2018-2023
Table 29. By Country - North America Measles, Mumps and Rubella (MMR) Vaccines Sales, (K Doses), 2024-2032
Table 30. By Country - Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2024-2032
Table 32. By Country - Europe Measles, Mumps and Rubella (MMR) Vaccines Sales, (K Doses), 2018-2023
Table 33. By Country - Europe Measles, Mumps and Rubella (MMR) Vaccines Sales, (K Doses), 2024-2032
Table 34. By Region - Asia Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2024-2032
Table 36. By Region - Asia Measles, Mumps and Rubella (MMR) Vaccines Sales, (K Doses), 2018-2023
Table 37. By Region - Asia Measles, Mumps and Rubella (MMR) Vaccines Sales, (K Doses), 2024-2032
Table 38. By Country - South America Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2024-2032
Table 40. By Country - South America Measles, Mumps and Rubella (MMR) Vaccines Sales, (K Doses), 2018-2023
Table 41. By Country - South America Measles, Mumps and Rubella (MMR) Vaccines Sales, (K Doses), 2024-2032
Table 42. By Country - Middle East & Africa Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2024-2032
Table 44. By Country - Middle East & Africa Measles, Mumps and Rubella (MMR) Vaccines Sales, (K Doses), 2018-2023
Table 45. By Country - Middle East & Africa Measles, Mumps and Rubella (MMR) Vaccines Sales, (K Doses), 2024-2032
Table 46. Medlmmune Company Summary
Table 47. Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Product Offerings
Table 48. Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 49. Medlmmune Key News & Latest Developments
Table 50. Johnson & Johnson Company Summary
Table 51. Johnson & Johnson Measles, Mumps and Rubella (MMR) Vaccines Product Offerings
Table 52. Johnson & Johnson Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 53. Johnson & Johnson Key News & Latest Developments
Table 54. Merck Company Summary
Table 55. Merck Measles, Mumps and Rubella (MMR) Vaccines Product Offerings
Table 56. Merck Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 57. Merck Key News & Latest Developments
Table 58. Sanofi Company Summary
Table 59. Sanofi Measles, Mumps and Rubella (MMR) Vaccines Product Offerings
Table 60. Sanofi Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 61. Sanofi Key News & Latest Developments
Table 62. Serum Company Summary
Table 63. Serum Measles, Mumps and Rubella (MMR) Vaccines Product Offerings
Table 64. Serum Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 65. Serum Key News & Latest Developments
Table 66. Bavarian Nordic Company Summary
Table 67. Bavarian Nordic Measles, Mumps and Rubella (MMR) Vaccines Product Offerings
Table 68. Bavarian Nordic Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 69. Bavarian Nordic Key News & Latest Developments
Table 70. Astellas Pharma Company Summary
Table 71. Astellas Pharma Measles, Mumps and Rubella (MMR) Vaccines Product Offerings
Table 72. Astellas Pharma Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 73. Astellas Pharma Key News & Latest Developments
Table 74. Emergent BioSolutions Company Summary
Table 75. Emergent BioSolutions Measles, Mumps and Rubella (MMR) Vaccines Product Offerings
Table 76. Emergent BioSolutions Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 77. Emergent BioSolutions Key News & Latest Developments
Table 78. GlaxoSmithKline Company Summary
Table 79. GlaxoSmithKline Measles, Mumps and Rubella (MMR) Vaccines Product Offerings
Table 80. GlaxoSmithKline Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 81. GlaxoSmithKline Key News & Latest Developments
Table 82. Pfizer Company Summary
Table 83. Pfizer Measles, Mumps and Rubella (MMR) Vaccines Product Offerings
Table 84. Pfizer Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 85. Pfizer Key News & Latest Developments
Table 86. CSL Company Summary
Table 87. CSL Measles, Mumps and Rubella (MMR) Vaccines Product Offerings
Table 88. CSL Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 89. CSL Key News & Latest Developments
Table 90. Measles, Mumps and Rubella (MMR) Vaccines Production Capacity (K Doses) of Key Manufacturers in Global Market, 2021-2023 (K Doses)
Table 91. Global Measles, Mumps and Rubella (MMR) Vaccines Capacity Market Share of Key Manufacturers, 2021-2023
Table 92. Global Measles, Mumps and Rubella (MMR) Vaccines Production by Region, 2018-2023 (K Doses)
Table 93. Global Measles, Mumps and Rubella (MMR) Vaccines Production by Region, 2024-2032 (K Doses)
Table 94. Measles, Mumps and Rubella (MMR) Vaccines Market Opportunities & Trends in Global Market
Table 95. Measles, Mumps and Rubella (MMR) Vaccines Market Drivers in Global Market
Table 96. Measles, Mumps and Rubella (MMR) Vaccines Market Restraints in Global Market
Table 97. Measles, Mumps and Rubella (MMR) Vaccines Raw Materials
Table 98. Measles, Mumps and Rubella (MMR) Vaccines Raw Materials Suppliers in Global Market
Table 99. Typical Measles, Mumps and Rubella (MMR) Vaccines Downstream
Table 100. Measles, Mumps and Rubella (MMR) Vaccines Downstream Clients in Global Market
Table 101. Measles, Mumps and Rubella (MMR) Vaccines Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Measles, Mumps and Rubella (MMR) Vaccines Segment by Type in 2022
Figure 2. Measles, Mumps and Rubella (MMR) Vaccines Segment by Application in 2022
Figure 3. Global Measles, Mumps and Rubella (MMR) Vaccines Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Measles, Mumps and Rubella (MMR) Vaccines Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue, 2018-2032 (US$, Mn)
Figure 7. Measles, Mumps and Rubella (MMR) Vaccines Sales in Global Market: 2018-2032 (K Doses)
Figure 8. The Top 3 and 5 Players Market Share by Measles, Mumps and Rubella (MMR) Vaccines Revenue in 2022
Figure 9. By Type - Global Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2022 & 2032
Figure 10. By Type - Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share, 2018-2032
Figure 11. By Type - Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share, 2018-2032
Figure 12. By Type - Global Measles, Mumps and Rubella (MMR) Vaccines Price (USD/Dose), 2018-2032
Figure 13. By Application - Global Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2022 & 2032
Figure 14. By Application - Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share, 2018-2032
Figure 15. By Application - Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share, 2018-2032
Figure 16. By Application - Global Measles, Mumps and Rubella (MMR) Vaccines Price (USD/Dose), 2018-2032
Figure 17. By Region - Global Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2022 & 2032
Figure 18. By Region - Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share, 2018 VS 2022 VS 2032
Figure 19. By Region - Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share, 2018-2032
Figure 20. By Region - Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share, 2018-2032
Figure 21. By Country - North America Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share, 2018-2032
Figure 22. By Country - North America Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share, 2018-2032
Figure 23. US Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2018-2032
Figure 24. Canada Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2018-2032
Figure 25. Mexico Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2018-2032
Figure 26. By Country - Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share, 2018-2032
Figure 27. By Country - Europe Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share, 2018-2032
Figure 28. Germany Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2018-2032
Figure 29. France Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2018-2032
Figure 30. U.K. Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2018-2032
Figure 31. Italy Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2018-2032
Figure 32. Russia Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2018-2032
Figure 33. Nordic Countries Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2018-2032
Figure 34. Benelux Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2018-2032
Figure 35. By Region - Asia Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share, 2018-2032
Figure 36. By Region - Asia Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share, 2018-2032
Figure 37. China Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2018-2032
Figure 38. Japan Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2018-2032
Figure 39. South Korea Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2018-2032
Figure 40. Southeast Asia Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2018-2032
Figure 41. India Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2018-2032
Figure 42. By Country - South America Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share, 2018-2032
Figure 43. By Country - South America Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share, 2018-2032
Figure 44. Brazil Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2018-2032
Figure 45. Argentina Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2018-2032
Figure 46. By Country - Middle East & Africa Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share, 2018-2032
Figure 47. By Country - Middle East & Africa Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share, 2018-2032
Figure 48. Turkey Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2018-2032
Figure 49. Israel Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2018-2032
Figure 50. Saudi Arabia Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2018-2032
Figure 51. UAE Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$, Mn), 2018-2032
Figure 52. Global Measles, Mumps and Rubella (MMR) Vaccines Production Capacity (K Doses), 2018-2032
Figure 53. The Percentage of Production Measles, Mumps and Rubella (MMR) Vaccines by Region, 2022 VS 2032
Figure 54. Measles, Mumps and Rubella (MMR) Vaccines Industry Value Chain
Figure 55. Marketing Channels
